市場調查報告書
商品編碼
1003479

血液相容性聚合物的全球市場 (2020年∼2027年)

Global Blood Compatible Polymers Market - 2020-2027

出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 約2個工作天內

價格

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

  • 全貌
  • 簡介
  • 目錄
簡介

“血液相容性”是指可以與血液接觸而不會引起不良反應的材料或裝置。在過去的 20 年裡,將各種合成和天然聚合物用於生物醫學目的取得了巨大進步,許多生物材料和血液接觸裝置現在用於心血管、肌肉和牙科應用,特別是在亞太國家,由於心力衰竭的高死亡率,預計市場將顯著擴大。

本報告提供全球血液相容性聚合物的市場相關分析,提供市場規模趨勢預測,及表面·各類型·各用途·各終端用戶·各地區的詳細趨勢,主要的推動及阻礙市場要素,主要企業的簡介等相關調查。

目錄

第1章 全球血液相容性聚合物市場:分析方法·範圍

第2章 全球血液相容性聚合物市場:市場定義和概要

第3章 全球血液相容性聚合物市場:摘要整理

第4章 全球血液相容性聚合物市場:市場動態

  • 對市場的影響要素
    • 促進因素
    • 阻礙因素
    • 市場機會
    • 影響力分析

第5章 全球血液相容性聚合物市場:產業分析

  • 波特的五力分析
  • 法規分析
  • 供應鏈分析
  • 價格分析
  • 貿易分析

第6章 全球血液相容性聚合物市場:各表面

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各表面
    • 市場向心力指數:各表面
  • 超親水性表面
    • 簡介
    • 市場規模 (以金額為準,2018∼2027年)·與前一年同期相比成長率 (YoY) (2018∼2027年)
  • 微相分離網域表面
  • 生物薄膜類似表面
  • 生物活性分子相抱表面

第7章 全球血液相容性聚合物市場:各類型

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各類型
    • 市場向心力指數:各類型
  • 聚丙烯
  • 聚乙烯
  • 聚(石風)
  • 聚醚醚酮
  • 聚四氟乙烯
  • 聚氯乙烯
  • 聚醚(石風)
  • 聚甲基丙烯酸甲酯
  • 其他

第8章 全球血液相容性聚合物市場:各用途

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各用途
    • 市場向心力指數:各用途
  • 人工水晶體
  • 血管移植片
  • 人工髖關節
  • 替代心臟瓣膜
  • 人工心臟瓣膜
  • 心室輔助裝置
  • 其他

第9章 全球血液相容性聚合物市場:各終端用戶

  • 簡介
    • 市場規模的分析與與前一年同期相比成長率 (YoY):各終端用戶
    • 市場向心力指數:各終端用戶
  • 藥物輸送設備
  • 人組織工程
  • 生物醫學
  • 血液接觸設備

第10章 全球血液相容性聚合物市場:各地區

  • 簡介
    • 市場規模和與前一年同期相比成長率 (YoY):各地區
    • 市場向心力指數:各地區
  • 北美
    • 簡介
    • 域內市場固有趨勢
    • 市場規模和與前一年同期相比成長率 (YoY):各表面
    • 市場規模和與前一年同期相比成長率 (YoY):各類型
    • 市場規模和與前一年同期相比成長率 (YoY):各用途
    • 市場規模和與前一年同期相比成長率 (YoY):各終端用戶
    • 市場規模和與前一年同期相比成長率 (YoY):各國
  • 歐洲
  • 南美
  • 亞太地區
  • 中東·非洲

第11章 全球血液相容性聚合物市場:競爭情形

  • 競爭方案
  • 市場定位/佔有率分析
  • 企業合併·收購 (M&A)的分析

第12章 全球血液相容性聚合物市場:企業簡介

  • Eastman Chemical Company.
    • 企業概要
    • 產品的組合/概要
    • 近幾年趨勢
    • 財務分析:概要
  • Baxter International Inc.
  • Evonik Industries AG
  • AdvanSource Biomaterials Corporation
  • TOPAS Advanced Polymers GmbH
  • Mitsui Chemicals
  • BASF SE
  • Exxon Mobil Corporation
  • Lyondell Basell Industries
  • Reliance Industries Limited

第13章 關於DataM Intelligence

目錄

Market Overview

"Blood-compatibility" can be characterized as the property of a material or device that grants it to work in contact with blood without actuating adverse reactions. The use of different polymers, both synthetic and natural, for biomedical purposes has gained such enormous progress during the most recent twenty years that a variety of biomaterials and blood-contacting devices are as of now being utilized in cardiovascular, muscular, and dental applications all through the world. Implantation of heart valves, catheters, and so on has become pretty much a standard undertaking in a cardiovascular medical procedure. The vast majority of these gadgets are being manufactured from polymers, and the fundamental prerequisites for growing a particularly biocompatible polymer are exceptionally rigid. It must be sterilizable, nontoxic, effectively fabricable, and resistant to mechanical strains, should not produce allergy or hypersensitivity, not impel any inflammatory reaction, and it also should not degrade chemically.

The global Blood Compatible Polymer market is estimated to reach USD XX billion by 2027 from the recorded market size of worth USD XX billion in 2019, growing at a CAGR of XX% during the forecast period.

Market Dynamics

The healthcare sector is a significant market for Blood Compatible Polymers. The pharmaceutical and biomedical industries drive the blood-compatible polymers market. They have substantial benefits over the other biomedical gadgets; moreover, they have been utilized widely utilized throughout recent years. Blood compatible polymers should have a particular composition of different polymers. Many of the procedures are brought into the application to acquire polymers' desired properties to make them blood compatible.

Increasing demand for artificial organs is expected to drive market growth during the forecast period.

With expanding interest in artificial organs which are used in contact with blood to fill in for different body functions like circulation, the disposal of waste and gas exchange, biomaterials with solid antithrombogenicity have been enormously required. When in contact with blood, artificial surfaces, for the most part, induce platelet adhesion and subsequent activation, which can prompt thrombus formation accompanied by the development of an insoluble fibrin network. Subsequently, one promising path for making material surfaces with thromboresistant properties is the design of surfaces eliminating adhering platelets' activation process. According to research, there has been a high rise in pacemakers' demand; moreover, it is expected to increase significantly between 2016 and 2023. Pacemakers are an essential live-saving implantable device for individuals living with certain heart conditions. It was estimated that there were about 1.14 million pacemakers globally in 2016, and by 2023, this number is expected to increase to 1.43 million units.

Rising demand in clinical dental applications is likely to drive the market growth during the forecast period.

Over the last few decades, polymeric materials for clinical dental applications have been created with unique properties and different functionalities. Dental composite resins are common materials used to reestablish the structural integrity of teeth. The material used to manufacture the dental replacement base is an acrylic sap produced using a combination of methyl-methacrylate (MMA) and poly (methyl methacrylate) (PMMA). Polymethyl methacrylate (PMMA) is commonly used for prosthetic dental applications, including the fabrication of artificial teeth, denture bases, dentures, obturators, orthodontic retainers, temporary or provisional crowns, and for the repair of dental prostheses. According to a report, the market revenue of PMMA in 2015 in the U.S. was nearly around 427 million U.S. dollars, and it is projected that by 2025, the market revenue of PMMA will be some 777 million U.S. dollars.

Raising environmental concerns is likely to hinder the market growth during the forecast period.

One key reason hindering the market growth is the rising environmental concerns among humanity for preserving nature's likelihood. Birds are very susceptible to toxicity by PTFE. Teflon toxicosis is known as exposed lungs begin to hemorrhage and fill up with fluid, drowning the bird from the inside (Green Living Tips, 2018). The most significant concern in the discussion of poisonousness and PTFE is the presence of PFOA, which is utilized in the creation of PTFE. PFOA additionally doesn't separate and taints everything as well. According to research, Scientists who conducted a report on PFOA found it present in the blood of 96% of all the hundreds of children tested (Green Living Tips, 2018); moreover, fluorinated polymers such as PTFE release TFA in large amounts at high temperatures, and it enters the atmosphere and comes down to earth in rainwater (SCIENTIFIC AMERICAN, 2018). On burning, PTFE releases very toxic gases into the atmosphere, so the dumps are the worst possible places for the PTFE to end up, and the recycling process for PTEE is way too expensive and very much specialized.

Segment Analysis

By surface, the market is segmented into super-hydrophilic surface, micro-phase-separated domain surface, bio membrane-like surface, bioactive-molecules incorporating surface. By application, the market is segmented into Intraocular lens, Vascular grafts, Artificial hip joints, Substitute heart valves, Chitra heart valves, ventricular assist devices and others. By end-user, the market is segmented into drug delivery systems, tissue engineering, bio-medical and blood-contacting devices. By type, the market is segmented into polyethylene, polypropylene, polysulfone, polyetheretherketone, polytetrafluoroethylene, polyvinylchloride, polyethersulfone, poly (methyl methacrylate) and others. Polypropylene is generally utilized in clinical applications today due to its due to high chemical and bacterial resistance; moreover, the medical-grade PP exhibits good resistance to steam sterilization. Disposable syringes are the most common medical application of polypropylene. According to a report by Statista, Polypropylene is the world's second-largest plastic resin-based on production volume after polyethylene. The global production volume of polypropylene in 2018 amounted to 56 million metric tons, and by 2026, it is a forecast that production will amount to 88 million metric tons.

Geographical Analysis

Asia Pacific dominates the market for Blood Compatible Polymers due to the growing demand in the medical industry. Increasing pollution is the critical factor for the medical industry's growth due to rising cardiovascular diseases across the region. Heart failure (HF) is a major global public health problem, and it is very prominent in Asian countries. Heart disease is the leading cause of death globally - causing one-third of deaths in 2019 -and the death count continues to rise. China had the most elevated number of coronary illness passings a year ago, trailed by India, Russia, the United States and Indonesia.

Next to Asia-pacific, North America, and South America are the regions seeking high market growth in the forecast period. Cardiovascular infections (CVD) are the primary sources of death in the Americas, representing 33.7% of total death rates, with higher mortality esteems in Guyana, Trinidad and Tobago, and Venezuela. In any event, 48% of U.S. grown-ups have some type of cardiovascular infection, based on the American Heart Association's latest statistics. Moreover, the recent advancements in the medical industry in the region favor the growth of the market in the forecast period.

Europe is also expected to witness the fastest growing blood-compatible polymer market due to the increasing demand of the medical industry and high technological advancements. Spain has been a leading country in performing a successful heart transplant. During 2020, the number of successful heart transplants performed in Spain reached to 278cases. These are the key regions seeking.

Competitive Landscape

The Blood Compatible Polymers market is fragmented with the presence of regional and global players. The competitive contour lies with the increase in the regional company and growing investment in upstream application. Baxter International Inc., Eastman Chemical Company, Evonik Industries AG, Sanofi, AdvanSource Biomaterials Corporation, TOPAS Advanced Polymers GmbH, Mitsui Chemicals, BASF SE, Exxon Mobil Corporation, Lyondell Basell Industries, Reliance Industries Limited and Sinopec are the major player in the market. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, contributing to growing the Blood Compatible Polymers market globally.

BASF

It is a German multinational chemical company and the largest chemical producer in the world. BASF manufactures and markets the ever-in-demand polyether polyols (PEOL) under the brand names, Lupranol® and Plural. With changes in the outer climate, for example, the COVID-19 pandemic, there are considerably even stronger societal needs for health and well-being. While reacting quickly to these changes, they plan to provide products that add to improved personal satisfaction and providing quality of life. According to a report, BASF has designed to invest in expanding the polyurethane dispersion business in water-based polyurethane dispersions at its Castellbisbal site in Spain. This expansion will not only allow BASF to increase its production capacity by 30 percent but also meet the rising demand for polyurethane dispersions.

Table of Contents

1. Global Blood Compatible Polymers Market Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Global Blood Compatible Polymers Market- Market Definition and Overview

3. Global Blood Compatible Polymers Market- Executive Summary

  • 3.1. Market Snippet by Surface
  • 3.2. Market Snippet by Type
  • 3.3. Market Snippet by Application
  • 3.4. Market Snippet by End User
  • 3.5. Market Snippet by Region

4. Global Blood Compatible Polymers Market-Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
    • 4.1.2. Restraints
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Global Blood Compatible Polymers Market- Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Regulatory Analysis
  • 5.3. Supply Chain Analysis
  • 5.4. Pricing Analysis
  • 5.5. Trade Analysis

6. Global Blood Compatible Polymers Market- By Surface

  • 6.1. Introduction
    • 6.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 6.1.2. Market Attractiveness Index, By Type
  • 6.2. Super-hydrophilic surface *
    • 6.2.1. Introduction
    • 6.2.2. Market Size Analysis, USD Mn, 2018-2027 and Y-o-Y Growth Analysis (%), 2018-2027
  • 6.3. Micro-phase-separated domain surface,
  • 6.4. Bio membrane-like surface,
  • 6.5. Bioactive-molecules incorporating surface

7. Global Blood Compatible Polymers Market- By Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Measuring Value
    • 7.1.2. Market Attractiveness Index, By Measuring Value
  • 7.2. Polypropylene *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis, USD Mn, 2018-2027 and Y-o-Y Growth Analysis (%), 2018-2027
  • 7.3. Polyethylene,
  • 7.4. Polysulfone,
  • 7.5. Polyetheretherketone,
  • 7.6. Polytetrafluoroethylene,
  • 7.7. Polyvinylchloride,
  • 7.8. Polyethersulfone,
  • 7.9. Poly (methyl methacrylate)
  • 7.10. Others.

8. Global Blood Compatible Polymers Market- By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Intraocular lens *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis, USD Mn, 2018-2027 and Y-o-Y Growth Analysis (%), 2018-2027
  • 8.3. Vascular grafts
  • 8.4. Artificial hip joints
  • 8.5. Substitute heart valves
  • 8.6. Chitra heart valves
  • 8.7. Ventricular assist devices
  • 8.8. Others.

9. Global Blood Compatible Polymers Market- By End User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User.
    • 9.1.2. Market Attractiveness Index, By End User
  • 9.2. Drug delivery system *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis, USD Mn, 2018-2027 and Y-o-Y Growth Analysis (%), 2018-2027
  • 9.3. Tissue engineering
  • 9.4. Bio-medical
  • 9.5. Blood contacting devices

10. Global Blood Compatible Polymers Market- By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surface
    • 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.2.7.1. United States
      • 10.2.7.2. Canada
      • 10.2.7.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surface
    • 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.3.7.1. Germany
      • 10.3.7.2. United Kingdom
      • 10.3.7.3. France
      • 10.3.7.4. Italy
      • 10.3.7.5. Spain
      • 10.3.7.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surface
    • 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 10.4.7.1. Brazil
      • 10.4.7.2. Argentina
      • 10.4.7.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surface
    • 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    • 10.5.8.
      • 10.5.8.1. China
      • 10.5.8.2. India
      • 10.5.8.3. Japan
      • 10.5.8.4. Australia
      • 10.5.8.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Surface
    • 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
    • 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 10.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
    • 10.6.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

11. Global Blood Compatible Polymers Market Competitive Landscape

  • 11.1. Competitive Scenario
  • 11.2. Market Positioning/Share Analysis
  • 11.3. Mergers and Acquisitions Analysis

12. Global Blood Compatible Polymers Market Company Profiles

  • 12.1. Eastman Chemical Company.*
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Baxter International Inc.
  • 12.3. Evonik Industries AG
  • 12.4. AdvanSource Biomaterials Corporation
  • 12.5. TOPAS Advanced Polymers GmbH
  • 12.6. Mitsui Chemicals
  • 12.7. BASF SE
  • 12.8. Exxon Mobil Corporation
  • 12.9. Lyondell Basell Industries
  • 12.10. Reliance Industries Limited

13. Global Blood Compatible Polymers Market- DataM

  • 13.1. Appendix
  • 13.2. About Us and Services
  • 13.3. Contact Us